- HDACi Targets IKZF1 Deletion High-Risk Acute Lymphoblastic Leukemia By Inducing IKZF1 Expression and Rescuing IKZF1 Function in Vitro and In VivoHuang, Kangyu; Tang, Bingqing; Cai, Zihong; He, Xianjun; Li, Qiuli; Liu, Nannan; Lin, Dainan; Pan, Xinhua; Shi, Ce; Long, Zijie; Wang, Jinheng; Hu, Yumin; Li, Peng; Liu, Qifa; Zhou, Hongsheng63rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Atlanta, GA, 2021-12-11 To 2021-12-14.
- Chemotherapy or Hematopoietic Stem Cell Transplantation in B-Lineage Acute Lymphoblastic Leukemia Patients Based on IKZF1 and MRD StatusDeng, Shiyu; Ou, Jiawang; Huang, Zicong; Zihong, Cai; Tang, Bingqing; Xu, Xiuli; Liu, Yiqian; Wu, Zhengwei; Liu, Qifa; Zhou, Hongsheng64th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), New Orleans, LA, 2022-12-10 To 2022-12-13.
- Dynamics of Minimal Residual Disease Defines a Novel Risk-Classification and the Role of Allo-HSCT in Adult Ph-Negative B Cell Acute Lymphoblastic LeukemiaZihong, Cai; Tang, Bingqing; Xu, Xiuli; Huang, Zicong; Liu, Qifa; Zhou, Hongsheng64th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), New Orleans, LA, 2022-12-10 To 2022-12-13.
会议论文
IKZF1deletions Coupled with CD20 Expression Represents a Novel High-Risk Subtype in Adult B-Cell Progenitor Acute Lymphoblastic Leukemia
7阅读
